Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center

Adverse events, short- and long-term outcomes of extra corporeal liver therapy in the intensive care unit: 16 years experience with MARS® in a single center

Abstract Background Molecular Adsorbent Recirculating System (MARS®) is a non-biological artificial liver device. The benefit risk ratio between uncertain clinical effects and potential adverse events remains difficult to assess. We sought to describe adverse events related to MARS® therapy as well...

Full description

Bibliographic Details
Main Authors: Clément Monet, Audrey De Jong, Yassir Aarab, Lauranne Piron, Albert Prades, Julie Carr, Fouad Belafia, Gérald Chanques, Boris Guiu, Georges-Philippe Pageaux, Samir Jaber
Format: Article
Language:English
Published: BMC 2022-09-01
Series:Critical Care
Subjects:
MARS®
Liver dialysis
Liver failure
Pruritus
Critical care
Online Access:https://doi.org/10.1186/s13054-022-04165-z

Internet

https://doi.org/10.1186/s13054-022-04165-z

Similar Items